 Home > Active Ingredient News > Antitumor Therapy > Eur Urol Focus: What are the long-term outcomes of thulium laser enucleation of the prostate?

Eur Urol Focus: What are the long-term outcomes of thulium laser enucleation of the prostate?

 Last Update: 2022-02-19
 Source: Internet
 Author: User

Tags

3 8 barb

supplements quality

hazard diamond

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Benign prostatic hyperplasia (BPE) is one of the most common diseases in older men, and its incidence increases almost linearly with age.

Quality of Life

Thulium laser excision of the prostate (ThuLEP) is an established regimen for benign prostatic hyperplasia (BPE), but long-term efficacy has not been reported

Thulium laser excision of the prostate (ThuLEP) is an established regimen for benign prostatic hyperplasia (BPE), but long-term efficacy has not been reported Thulium laser excision of the prostate (ThuLEP) is an established regimen for benign prostatic hyperplasia (BPE), but long-term efficacy has not been reported.

Durability of ThuLEP efficacy was demonstrated by investigating long-term efficacy and morbidity

The study included all patients treated with ThuLEP at a tertiary referral center in Germany between 2009 and 2021, who were retrospectively followed to investigate whether prostate adenoma persisted, re-grown (ReIP), or had long-term complications.

A total of 1,097 patients in the study received ThuLEP

Research design

In conclusion, the study investigated the long-term outcomes of thulium laser ablation of benign prostatic hyperplasia (BPE)

Univariate and Multivariate Cox Proportional Hazard Models Analysis of Predictors of Reintervention

Taken together, ThuLEP is a durable, effective and safe procedure with a low reintervention rate at 12 years

ThuLEP is a durable, effective and safe procedure with low reintervention rates at 12 years ThuLEP is a durable, effective and safe procedure with low reintervention rates at 12 years

Original source:

Britta Grüne, Fabian Siegel, Frank Waldbillig et al.

Long-term Reinterventions after Thulium Laser Enucleation of the Prostate: 12-Year Experience with more than 1000 Patients

leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Axitinib CAS 319460-85-0 supply high quality fast delivery best service

CAS No.: 319460-85-0

pharm grade

$2.53/KG EXW

Capmatinib hydrochloride CAS 1865733-40-9 high quality fast delivery best service

CAS No.: 1865733-40-9

pharm grade

$2.53/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

single use technology(195)

80 20 company(94)

united states logo(227)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.